BGBeatrix Grubeck-Loebenstein

Beatrix Grubeck-Loebenstein

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Beatrix Grubeck-Loebenstein has a total of 77 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Standardization and High-Throughput Measurement of T-Cell Responses to Vaccines

    by Dietmar Herndler-Brandstetter, Angelika Schwanninger, Beatrix Grubeck-Loebenstein

    INTRODUCTION Most present day phase I/II clinical vaccine trials aim to develop more effective preventive or therapeutic vaccine strategies for infectious diseases and cancer. These studies have at their foundation a comprehensively designed immunologic assay plan that will measure both quantitative and qualitative aspects of the vaccine-induced immune responses. At the same time, they must permit reliable comparisons to the immunogenicities of vaccine strategies that preceded them. During the past 15 years, the field of vaccine research has witnessed an informational and technological explosion that has served to refine vaccine strategies and develop highly complex tools for assessing vaccine immunogenicity and a link to efficacy. Many of these advances have been driven by the critical need to develop an effective AIDS vaccine that could impact on the worldwide epidemic. Although the immunologic ‘‘correlates of protection’’ against HIV infection have yet to be elucidated, most in the scientific community feel that a vaccine is needed that will elicit long-lived and broadly reactive humoral and cellular immune responses, both systemically and mucosally. For the currently licensed human vaccines in use today, the role of vaccine-induced T-cell responses in preventing infections or disease has been less well established than the role of neutralizing antibodies, although in many instances the basis for protection by these vaccines has never been clearly delineated.CHALLENGES ASSOCIATED WITH MEASURING VACCINE-INDUCED T-CELL RESPONSES Since most developmental vaccine strategies are built upon the concept of making incremental improvements on existing vaccines, the assays used in assessing immunogenicity must provide reliable comparative data. This aspect of vaccine testing demands that highly standardized and formally validated assays be used in providing immunologic end points. The assessment of vaccine-induced T-cell responses in the setting of phase I/II clinical trials presents formidable challenges that do not apply to routine serologic immunogenicity testing, although standardization of the latter is of equal importance. All too often, optimization and standardization efforts are focused on the sophisticated technologies used to measure antigen-specific T-cell responses, with very little attention paid to an important aspect of immunogenicity testing, the overall functional integrity of the clinical specimens, in most

  • Open Access

    The effect of chronological age on the inflammatory response of human fibroblasts

    by Juliane Wolf, Birgit Weinberger, Christoph R. Arnold, Andrea B. Maier, Rudi G.J. Westendorp, Beatrix Grubeck-Loebenstein


  • Open Access

    The immunoregulatory effects of CMV-infection in human fibroblasts and the impact on cellular senescence

    by Juliane Wolf, Birgit Weinberger, Beatrix Grubeck-Loebenstein

    Background: As a chronic antigenic stressor human Cytomegalovirus (CMV) contributes substantially to age-related alterations of the immune system. Even though monocytes have the greatest propensity for CMV-infection and seem to be an important host for the virus during latency, fibroblasts are also discussed to be target cells of CMV in vivo. However, little is known so far about general immunoregulatory properties of CMV in fibroblasts. We therefore investigated the immunoregulatory effects of CMV-infection in human lung fibroblasts and the impact on replicative senescence. Findings: We observed that CMV-infection led to the induction of several immunoregulatory host cell genes associated with the innate and adaptive immune system. These were genes of different function such as genes regulating apoptosis, cytokines/chemokines and genes that are responsible for the detection of pathogens. Some of the genes upregulated following CMV-infection are also upregulated during cellular senescence, indicating that CMV causes an immunological phenotype in fibroblasts, which is partially reminiscent of replicative senescent cells. Conclusion: In summary our results demonstrate that CMV not only affects the T cell pool but also induces inflammatory processes in human fibroblasts.


  • Open Access

    Upregulation of miR‐24 is associated with a decreased DNA damage response upon etoposide treatment in highly differentiated CD8+ T cells sensitizing them to apoptotic cell death

    by Stefan Brunner, Dietmar Herndler‐Brandstetter, Christoph R. Arnold, Gerrit Jan Wiegers, Andreas Villunger, Matthias Hackl, Johannes Grillari, María Moreno‐Villanueva, Alexander Bürkle, Beatrix Grubeck‐Loebenstein

    Summary: The life‐long homeostasis of memory CD8+ T cells as well as persistent viral infections have been shown to facilitate the accumulation of highly differentiated CD8+CD28− T cells, a phenomenon that has been associated with an impaired immune function in humans. However, the molecular mechanisms regulating homeostasis of CD8+CD28− T cells have not yet been elucidated. In this study, we demonstrate that the miR‐23∼24∼27 cluster is up‐regulated during post‐thymic CD8+ T‐cell differentiation in humans. The increased expression of miR‐24 in CD8+CD28− T cells is associated with decreased expression of the histone variant H2AX, a protein that plays a key role in the DNA damage response (DDR). Following treatment with the classic chemotherapeutic agent etoposide, a topoisomerase II inhibitor, apoptosis was increased in CD8+CD28− when compared to CD8+CD28+ T cells and correlated with an impaired DDR in this cell type. The reduced capacity of CD8+CD28− T cell to repair DNA was characterized by the automated fluorimetric analysis of DNA unwinding (FADU) assay as well as by decreased phosphorylation of H2AX at Ser139, of ATM at Ser1981, and of p53 at Ser15. Interleukin (IL)‐15 could prevent etoposide‐mediated apoptosis of CD8+CD28− T cells, suggesting a role for IL‐15 in the survival and the age‐dependent accumulation of CD8+CD28− T cells in humans.


  • Vaccination in the Elderly

    by Birgit Weinberger, Beatrix Grubeck-Loebenstein

  • Gain and Loss of T Cell Subsets in Old Age—Age-Related Reshaping of the T Cell Repertoire

    by Christoph R. Arnold, Juliane Wolf, Stefan Brunner, Dietmar Herndler-Brandstetter, Beatrix Grubeck-Loebenstein

    The immune system is affected by the aging process and undergoes significant age-related changes, termed immunosenescence. Different T cell subsets are affected by this process. Alterations within the bone marrow and thymus lead to a shift in the composition of the T cell repertoire from naïve to antigen-experienced T cells, thereby compromising the diversity of the T cell pool. Additional infection with latent pathogens such as cytomegalovirus aggravates this process. In this review, we focus on the major age-related changes that occur in the naïve and the antigen-experienced T cell population. We discuss the mechanisms responsible for the generation and maintenance of these subsets and how age-related changes can be delayed or prevented by clinical interventions.


  • Open Access

    Immunosenescence and Cytomegalovirus: where do we stand after a decade?

    by Graham Pawelec, Arne Akbar, Peter Beverley, Calogero Caruso, Evelyna Derhovanessian, Tamas Fülöp, Paul Griffiths, Beatrix Grubeck-Loebenstein, Klaus Hamprecht, Gerhard Jahn, et al.


  • Microarray analysis reveals similarity between CD8+CD28− T cells from young and elderly persons, but not of CD8+CD28+ T cells

    by Lutfan Lazuardi, Dietmar Herndler-Brandstetter, Stefan Brunner, Gerhard T. Laschober, Günter Lepperdinger, Beatrix Grubeck-Loebenstein

    We isolated highly purified CD8+CD28+ and CD8+CD28− T cell populations from healthy young and elderly persons for gene expression profiling using Affymetrix oligonucleotide microarrays. We demonstrate that the gene expression profile of CD8+CD28− T cells is very similar in young and elderly persons. In contrast, CD8+CD28+ in elderly differ from CD8+CD28+ in young persons. Hierarchical clustering revealed that CD8+CD28+ in elderly are located between CD8+CD28+ in young and CD8+CD28− (young and old) T cells regarding their differentiation state. Our study demonstrates a dichotomy of gene expression levels between CD8+CD28+ T cells in young and elderly persons but a similarity between CD8+CD28− T cells in young and elderly persons. As CD8+CD28+ T cells from elderly and young persons are distinct due to a different composition of the population, these results suggest that the gene expression profile does not depend on chronological age but depends on the differentiation state of the individual cell types.


  • Biology of Immune Responses to Vaccines in Elderly Persons

    by Birgit Weinberger, Dietmar Herndler‐Brandstetter, Angelika Schwanninger, Daniela Weiskopf, Beatrix Grubeck‐Loebenstein

    With increasing age, the human immune system undergoes characteristic changes, termed immunosenescence, which lead to increased incidence and severity of infectious diseases and to insufficient protection following vaccination. Functional defects and altered frequencies of innate and adaptive immune cells impair local responses at the site of vaccine injection, hamper the generation of primary responses to neoantigens, prevent the effective induction of memory lymphocytes, and decrease the effect of booster vaccination. As a result, antibody responses of elderly vaccinees are weaker and decline faster, and long-term protective effects of vaccination cannot be taken for granted in elderly persons. Improved vaccination strategies, new adjuvants, and new vaccines that specifically target the aged immune system will help to overcome the limitations of immunosenescence and ensure a better protection of the vulnerable elderly population.


  • The Efficacy of Vaccines to Prevent Infectious Diseases in the Elderly

    by Dietmar Herndler-Brandstetter, Beatrix Grubeck-Loebenstein

    Infectious diseases still represent a major challenge to human progress and survival. Especially elderly persons are more frequently and severely affected by infectious diseases and they display distinct features with respect to clinical presentation and treatment. Although vaccinations are considered a vital medical procedure for preventing morbidity and mortality caused by infectious diseases, the protective effect of vaccinations is abrogated in elderly persons. This is due to a decline in the functions of the immune system referred to as immunosenescence. The first part of this chapter will therefore summarize the status quo of the efficacy of vaccines in preventing morbidity and mortality caused by typical infectious diseases in the elderly, such as influenza, pneumonia and tuberculosis. The second part will then elucidate the underlying age-related mechanisms which may contribute to the decreased efficacy of vaccines. Based on the complex mechanisms involved in immunosenescence, strategies will be outlined which may be succesfful in enhancing protective immune responses following vaccination in elderly persons.